PubMed

Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic Peptide processing and adverse outcomes in blacks with systolic heart failure: results from the genetic risk assessment in heart failure substudy.

Rame JE, Tam SW, McNamara D, Worcel M, Sabolinski ML, Wu AH, Dries DL.

Circ Heart Fail. 2009 Nov;2(6):541-8. Epub 2009 Sep 28.PMID: 19919978 [PubMed - in process]Related articles

Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.

McNamara DM, Tam SW, Sabolinski ML, Tobelmann P, Janosko K, Venkitachalam L, Ofili E, Yancy C, Feldman AM, Ghali JK, Taylor AL, Cohn JN, Worcel M.

J Card Fail. 2009 Apr;15(3):191-8. Epub 2008 Dec 23.PMID: 19327620 [PubMed - indexed for MEDLINE]Related articles

Exploring the potential synergistic action of spironolactone on nitric oxide-enhancing therapy: insights from the African-American Heart Failure Trial.

Ghali JK, Tam SW, Sabolinski ML, Taylor AL, Lindenfeld J, Cohn JN, Worcel M.

J Card Fail. 2008 Nov;14(9):718-23. Epub 2008 Aug 9.PMID: 18995175 [PubMed - indexed for MEDLINE]Related articles

Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.

Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN; A-HeFT Investigators.

Am J Cardiovasc Drugs. 2007;7(5):373-80.PMID: 18041162 [PubMed - indexed for MEDLINE]Related articles

Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine: the V-HeFT paradox.

Tam SW, Sabolinski ML, Worcel M, Packer M, Cohn JN.

Clin Pharmacokinet. 2007;46(10):885-95.PMID: 17854237 [PubMed - indexed for MEDLINE]Related articles

Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial).

Yancy CW, Ghali JK, Braman VM, Sabolinski ML, Worcel M, Archambault WT, Franciosa JA.

Am J Cardiol. 2007 Aug 15;100(4):684-9. Epub 2007 Jun 26.PMID: 17697829 [PubMed - indexed for MEDLINE]Related articles

Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.

Cohn JN, Tam SW, Anand IS, Taylor AL, Sabolinski ML, Worcel M; A-HeFT Investigators.

J Card Fail. 2007 Jun;13(5):331-9.PMID: 17602978 [PubMed - indexed for MEDLINE]Related articles

Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.

Taylor AL, Ziesche S, Yancy CW, Carson P, Ferdinand K, Taylor M, Adams K, Olukotun AY, Ofili E, Tam SW, Sabolinski ML, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators.

Circulation. 2007 Apr 3;115(13):1747-53. Epub 2007 Mar 19.PMID: 17372175 [PubMed - indexed for MEDLINE]Related articlesFree article

Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial.

Anand IS, Tam SW, Rector TS, Taylor AL, Sabolinski ML, Archambault WT, Adams KF, Olukotun AY, Worcel M, Cohn JN.

J Am Coll Cardiol. 2007 Jan 2;49(1):32-9. Epub 2006 Dec 14.PMID: 17207719 [PubMed - indexed for MEDLINE]Related articles

Outcomes by gender in the African-American Heart Failure Trial.

Taylor AL, Lindenfeld J, Ziesche S, Walsh MN, Mitchell JE, Adams K, Tam SW, Ofili E, Sabolinski ML, Worcel M, Cohn JN; A-HeFT Investigators.

J Am Coll Cardiol. 2006 Dec 5;48(11):2263-7. Epub 2006 Nov 9.PMID: 17161257 [PubMed - indexed for MEDLINE]Related articles

Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial.

McNamara DM, Tam SW, Sabolinski ML, Tobelmann P, Janosko K, Taylor AL, Cohn JN, Feldman AM, Worcel M.

J Am Coll Cardiol. 2006 Sep 19;48(6):1277-82. Epub 2006 Aug 14.PMID: 16979018 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure.

Angus DC, Linde-Zwirble WT, Tam SW, Ghali JK, Sabolinski ML, Villagra VG, Winkelmayer WC, Worcel M; African-American Heart Failure Trial (A-HeFT) Investigators.

Circulation. 2005 Dec 13;112(24):3745-53.PMID: 16344404 [PubMed - indexed for MEDLINE]Related articlesFree article

Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.

Veves A, Falanga V, Armstrong DG, Sabolinski ML; Apligraf Diabetic Foot Ulcer Study.

Diabetes Care. 2001 Feb;24(2):290-5.PMID: 11213881 [PubMed - indexed for MEDLINE]Related articlesFree article

Behavior of tissue-engineered skin: a comparison of a living skin equivalent, autograft, and occlusive dressing in human donor sites.

Muhart M, McFalls S, Kirsner RS, Elgart GW, Kerdel F, Sabolinski ML, Hardin-Young J, Eaglstein WH.

Arch Dermatol. 1999 Aug;135(8):913-8.PMID: 10456339 [PubMed - indexed for MEDLINE]Related articlesFree article

Acute excisional wounds treated with a tissue-engineered skin (Apligraf).

Eaglstein WH, Alvarez OM, Auletta M, Leffel D, Rogers GS, Zitelli JA, Norris JE, Thomas I, Irondo M, Fewkes J, Hardin-Young J, Duff RG, Sabolinski ML.

Dermatol Surg. 1999 Mar;25(3):195-201.PMID: 10193966 [PubMed - indexed for MEDLINE]Related articles

Cultured skin as a 'smart material' for healing wounds: experience in venous ulcers.

Sabolinski ML, Alvarez O, Auletta M, Mulder G, Parenteau NL.

Biomaterials. 1996 Feb;17(3):311-20.PMID: 8745328 [PubMed - indexed for MEDLINE]Related articles

Differentiation of pemphigus antibodies of the vulgaris and follaceus types on monkey and guinea pig esophagus sections.

Sabolinski ML, Beutner EH, Chorzelski TP, Kumar V, Krasny SA, Bystryn JC.

Autoimmunity. 1990;5(3):229-32. No abstract available. PMID: 2129755 [PubMed - indexed for MEDLINE]Related articles

Substrate specificity of anti-epithelial antibodies of pemphigus vulgaris and pemphigus foliaceus sera in immunofluorescence tests on monkey and guinea pig esophagus sections.

Sabolinski ML, Beutner EH, Krasny S, Kumar V, Huang J, Chorzelski TP, Sampaio S, Bystryn JC.

J Invest Dermatol. 1987 May;88(5):545-9.PMID: 2437210 [PubMed - indexed for MEDLINE]Related articles